Aytu BioPharma (NASDAQ:AYTU) Trading 1.7% Higher

Aytu BioPharma, Inc. (NASDAQ:AYTUGet Free Report) shares shot up 1.7% during mid-day trading on Monday . The stock traded as high as $2.91 and last traded at $2.91. 8,656 shares traded hands during trading, a decline of 57% from the average session volume of 20,155 shares. The stock had previously closed at $2.86.

Aytu BioPharma Stock Down 1.4 %

The stock’s 50 day simple moving average is $3.02 and its two-hundred day simple moving average is $2.94. The company has a market cap of $16.90 million, a PE ratio of -1.08 and a beta of -1.41.

Aytu BioPharma (NASDAQ:AYTUGet Free Report) last posted its quarterly earnings data on Wednesday, May 15th. The company reported ($0.52) EPS for the quarter, beating analysts’ consensus estimates of ($0.64) by $0.12. Aytu BioPharma had a negative net margin of 14.60% and a negative return on equity of 31.31%. The firm had revenue of $17.99 million for the quarter.

Aytu BioPharma Company Profile

(Get Free Report)

Aytu Biopharma, Inc, a commercial-stage pharmaceutical company, focuses on commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates through two segments: Rx segment and Consumer Health segment. The Rx segment offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years and older, and Cotempla XR-ODT for patients from six to seventeen years old.

See Also

Receive News & Ratings for Aytu BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aytu BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.